How do I buy Silence Therapeutics (SLN) stock?

You can purchase shares of Silence Therapeutics (NASDAQ:SLN) through any online brokerage.View our list of the best stock brokerages

Who are Silence Therapeutics (SLN) competitors?

Other companies in Silence Therapeutics’s space includes: Zura Bio Ltd (NASDAQ:ZURA), Humacyte Inc (NASDAQ:HUMA), Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL), Voyager Therapeutics Inc (NASDAQ:VYGR) and Immuneering Corp (NASDAQ:IMRX).

What is the forecast, or price target, for Silence Therapeutics (SLN) stock?

Silence Therapeutics has a consensus price target of $39.67.

What is the current price for Silence Therapeutics (SLN)?

The stock price for Silence Therapeutics (NASDAQ: SLN) is $5.04 last updated January 16, 2026 at 7:19 PM EST.

Does Silence Therapeutics (SLN) pay a dividend?

There are no upcoming dividends for Silence Therapeutics.

When is Silence Therapeutics (NASDAQ:SLN) reporting earnings?

Silence Therapeutics does not have any upcoming earnings scheduled.

Is Silence Therapeutics (SLN) going to split?

There is no upcoming split for Silence Therapeutics.

What sector and industry does Silence Therapeutics (SLN) operate in?

Silence Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Silence Therapeutics (SLN) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates bot...

Comments